Penicillin hypersensitivity regimens for endocarditis caused by enterococci susceptible to penicillin and gentamicin

For adults and children with native or prosthetic valve enterococcal endocarditis susceptible to penicillin and gentamicin who report penicillin hypersensitivity, verify their allergy. In some patients it may be appropriate to directly delabel their allergy by taking an extensive allergy history (see Clinical history for initial assessment of patients reporting penicillin hypersensitivity). In patients whose penicillin allergy has been delabeled, a penicillin-based regimen should be used.

Seek expert advice for patients with a verified allergy. For patients who have had a nonsevere (immediate or delayed) or a severe immediate1 hypersensitivity reaction to a penicillin, options that an infectious diseases physician or clinical microbiologist may use include:

  • performing desensitisation
  • using vancomycin plus gentamicin (see dosage below).

For adults and children with native or prosthetic valve enterococcal endocarditis susceptible to penicillin and gentamicin who have had a severe delayed2 hypersensitivity reaction to a penicillin, a suitable regimen is:

vancomycin intravenously for 6 weeks; for initial dosing, see Intermittent vancomycin dosing for noncritically ill adults or Intermittent vancomycin dosing for young infants and children vancomycin vancomycin vancomycin

PLUS

gentamicin (adult and child) 1 mg/kg intravenously, 8-hourly for 6 weeks (monitor plasma concentration; see Principles of aminoglycoside use)3. gentamicin gentamicin gentamicin

Vancomycin is intrinsically not as effective against enterococci as penicillin; therefore, treatment must be given for 6 weeks. For patients with hypersensitivity to penicillins, if either gentamicin or vancomycin is contraindicated, seek expert advice.

1 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse.Return
2 Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return
3 For adults with obesity (body mass index 30 kg/m2 or more), use lean body weight to calculate the dose. For children with obesity, use adjusted body weight to calculate the dose.Return